Journal Basic Info
- Impact Factor: 0.285**
- H-Index: 6
- ISSN: 2638-4558
- DOI: 10.25107/2638-4558
Major Scope
- Psychiatry
- Infectious Disease
- Nursing
- Women’s Health Care
- Chemotherapy
- Urology Cases
- Signs and Symptoms-Clinical Findings
- Mental Health
Abstract
Citation: Clin Case Rep Int. 2022;6(1):1374.DOI: 10.25107/2638-4558.1374
Lack of Efficacy of Daratumumab in a Patient with Severe Refractory Rheumatoid Arthritis
Iñigo González Mazón, Enrique M Ocio, Mario Agudo Bilbao, Marcos López-Hoyos and Víctor M Martínez-Taboada
1 Department of Rheumatology, Marqués de Valdecilla University Hospital, Spain
Department of Hematology, Marqués de Valdecilla University Hospital, Spain
University of Cantabria, Spain
Department of Rheumatology, Hospital Sierrallana, Spain
Department of Immunology, Marqués de Valdecilla University Hospital, Spain
*Correspondance to: Víctor M Martínez-Taboada
PDF Full Text Case Study | Open Access
Abstract:
#
Keywords:
Rheumatoid arthritis; Refractory; Daratumumab
Cite the Article:
Mazón IG, Ocio EM, Bilbao MA, López- Hoyos M, Martínez-Taboada VM. Lack of Efficacy of Daratumumab in a Patient with Severe Refractory Rheumatoid Arthritis. Clin Case Rep Int. 2022; 6: 1374.
